GRANULES.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Stats
Dagens volum	635 712
Gjennomsnittsvolum	1.23M
Markedsverdi	101.92B
EPS	INR0 ( 2024-01-22 )
Neste inntjeningsdato	( INR0 ) 2024-05-13
Last Dividend	INR1.500 ( 2023-08-03 )
Next Dividend	INR0 ( N/A )
P/E	25.83
ATR14	INR0.317 (0.08%)

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.47 (neutral)

Signal:(68.877) Neutral

Granules India Limited Korrelasjon

10 Mest positive korrelasjoner
RELAXO.NS	0.916
PIXTRANS.NS	0.913
LAKSHVILAS.NS	0.912
JKTYRE.NS	0.91
GLAND.NS	0.908
DMART.NS	0.907
DIXON.NS	0.906
HERITGFOOD.NS	0.904
BRFL.NS	0.903
PIDILITIND.NS	0.902

10 Mest negative korrelasjoner
GTNIND.NS	-0.91
GENCON.NS	-0.904
DFMFOODS.NS	-0.897
MBAPL.NS	-0.891
LTGILTBEES.NS	-0.891
GRPLTD.NS	-0.886
MAGNUM.NS	-0.876
RAJRILTD.NS	-0.868
TOUCHWOOD.NS	-0.862
ACI.NS	-0.861

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Granules India Limited Korrelasjon - Valuta/Råvare

0.16
( neutral )

0.36
( neutral )

0.26
( neutral )

-0.63
( weak negative )

-0.56
( weak negative )

Granules India Limited Økonomi

Annual	2022
Omsetning:	INR45.12B
Bruttogevinst:	INR22.05B (48.86 %)
EPS:	INR21.05

FY	2022
Omsetning:	INR45.12B
Bruttogevinst:	INR22.05B (48.86 %)
EPS:	INR21.05

FY	2022
Omsetning:	INR37.27B
Bruttogevinst:	INR17.68B (47.44 %)
EPS:	INR16.66

FY	2021
Omsetning:	INR32.38B
Bruttogevinst:	INR17.83B (55.06 %)
EPS:	INR22.05

Financial Reports:

No articles found.

Granules India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.750 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Granules India Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.26 - low (41.50%) | Divividend Growth Potential Score: 3.34 - Decrease likely (33.20%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.125	2005-12-01
Last Dividend	INR1.500	2023-08-03
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	41	--
Total Paid Out	INR11.55	--
Avg. Dividend % Per Year	0.29%	--
Score	2.67	--
Div. Sustainability Score	4.26
Div.Growth Potential Score	3.34
Div. Directional Score	3.80	--

Next Divdend (Est)
(2024-09-25)

INR1.614 Estimate 3.60 %

Dividend Stability

0.29 Very Poor

Dividend Score

2.67

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR1.250	1.25%
2019	INR1.000	1.10%
2020	INR1.000	0.82%
2021	INR1.500	0.42%
2022	INR1.000	0.30%
2023	INR1.500	0.47%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SOBHA.NS	Dividend Junior	2023-07-28	Annually	18	0.43%
MMP.NS	Dividend Junior	2023-08-18	Annually	4	0.49%
HDFC.NS	Dividend Junior	2023-05-16	Annually	23	0.85%
BHAGCHEM.NS	Dividend Junior	2023-07-27	Annually	4	0.14%
RAIN.NS	Dividend Junior	2023-05-19	Annually	18	0.39%
KIRLOSBROS.NS	Dividend Junior	2023-07-25	Annually	17	0.99%
EMMBI.NS	Dividend Junior	2023-08-04	Annually	14	0.28%
AKSHARCHEM.NS	No Dividend Player	2023-09-20	Annually	7	0.34%
SUPRAJIT.NS	Dividend Junior	2023-09-18	Semi-Annually	20	0.45%
NBIFIN.NS	Dividend Junior	2023-08-11	Sporadic	8	0.01%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0873	1.500	8.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.136	1.500	9.60	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.59	1.000	8.67	8.67	[3 - 30]
operatingCashFlowPerShareTTM	12.77	2.00	5.74	10.00	[0 - 30]
freeCashFlowPerShareTTM	12.77	2.00	3.61	7.23	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.519	1.000	4.68	4.68	[0.2 - 0.8]
operatingProfitMarginTTM	0.140	1.000	9.21	9.21	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.26

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.95	1.000	7.48	0	[1 - 100]
returnOnEquityTTM	0.136	2.50	9.74	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	12.77	2.00	5.74	7.23	[0 - 30]
dividendYielPercentageTTM	0.354	1.500	1.139	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.77	2.00	5.74	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0684	1.000	-0.790	0	[0.1 - 0.5]
Total Score				3.34

Granules India Limited

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.